News

Symptoms of inflammatory bowel disease (IBD) range from diarrhea and abdominal pain to nausea, fever, loss of appetite, ...
Reformulated With InnoSlim®, α-Lacys Reset®, and Capsimax® to Support Multi-Pathway Metabolic Function Without a ...
A 14-month randomized trial in older African American adults with obesity found that adopting a Mediterranean diet, with or ...
Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.
Research indicates that specific plant-based supplements, combined with exercise, can improve cardiometabolic markers in ...
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...
Data from 32 studies concluded that the impact of exercise is modest in terms of meaningful weight loss. Caloric restriction ...
Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being.
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.
Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...
The Saudi Arabia weight loss market reached USD 1.6 billion in 2024 and is projected to climb to USD 2.7 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.68% from 2025 to 2033.